See on Scoop.it – MyHealthShare Medical Reporter
SAN ANTONIO — Treatment with the bisphosphonate zoledronate did not improve outcomes for women with chemoresistant breast cancer, according to initial results of a phase III clinical trial presented here at the 2013 San Antonio Breast Cancer…
See on www.aacr.org
Advertisements